[
    [
        {
            "time": "2018-03-15",
            "original_text": "Pfizer Amends Xtandi Study Protocols to Speed Up Completion",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Xtandi",
                    "Study",
                    "Protocols",
                    "Speed Up",
                    "Completion"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Pfizer Amends Xtandi Study Protocols to Speed Up Completion",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-20",
            "original_text": "J&J to Appeal as Judge Confirms Jury Order in Talc Case",
            "features": {
                "keywords": [
                    "J&J",
                    "Appeal",
                    "Judge",
                    "Jury",
                    "Order",
                    "Talc",
                    "Case"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "J&J to Appeal as Judge Confirms Jury Order in Talc Case",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-05-10",
            "original_text": "Large-Cap Pharma Rebounds: 2 Stocks to Boost Your Portfolio",
            "features": {
                "keywords": [
                    "Large-Cap",
                    "Pharma",
                    "Rebounds",
                    "Stocks",
                    "Portfolio"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Large-Cap Pharma Rebounds: 2 Stocks to Boost Your Portfolio",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-06-05",
            "original_text": "Xtandi Trials: Pfizer and Astella Amend the Protocols",
            "features": {
                "keywords": [
                    "Xtandi",
                    "Trials",
                    "Pfizer",
                    "Astella",
                    "Amend",
                    "Protocols"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Xtandi Trials: Pfizer and Astella Amend the Protocols",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-15",
            "original_text": "How Incyte’s Product Portfolio Is Looking in August",
            "features": {
                "keywords": [
                    "Incyte",
                    "Product",
                    "Portfolio",
                    "August"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "How Incyte’s Product Portfolio Is Looking in August",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]